• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 JDTic 的结合和解离,计算洞察阿片受体的亚型选择性和“信息-地址-功效”机制。

Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.

机构信息

Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.

Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Acta Pharmacol Sin. 2018 Mar;39(3):482-491. doi: 10.1038/aps.2017.132. Epub 2017 Oct 19.

DOI:10.1038/aps.2017.132
PMID:29047460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843831/
Abstract

In drug design and discovery, binding affinity and selectivity are two basic properties of a drug candidate. Opioid receptors (ORs) are the main targets of strong analgesics. Like some other class A members of G-protein-coupled receptors (GPCRs), ORs exhibit complex selectivity on their ligands. The diversity of binding activity and selectivity among opioids has deeply attracted researchers for a long time. To investigate the subtype selectivity of μ, δ and κ ORs in detail, using the κ-selective antagonist JDTic as a probe, we performed a series of computational simulations, including molecular dynamics and metadynamics, on JDTic-μ/δ/κ-OR complexes. From the simulations, we found that the decisive factor of JDTic selectivity on the μ-subtype was the 2.63 position, which affected the efficacy of JDTic through changing the dynamics of the Q residue. In addition to the 2.63-position residue, the 7.35 position was the other crucial aspect of JDTic selectivity for the δ-subtype. Based on the results, we suggest a new concept, the "message-address-efficacy" hypothesis, to explain the relationships among the affinity, selectivity and function between ORs and opioids. Thus, all the detailed dynamics of JDTic-bound ORs might be helpful to deeply understand the subtype selectivity and binding mechanisms of other GPCRs.

摘要

在药物设计和发现中,结合亲和力和选择性是药物候选物的两个基本特性。阿片受体(ORs)是强镇痛药的主要靶点。与其他一些 G 蛋白偶联受体(GPCRs)的 A 类成员一样,ORs 对其配体表现出复杂的选择性。阿片类药物在结合活性和选择性方面的多样性长期以来一直深深吸引着研究人员。为了详细研究 μ、δ 和 κ ORs 的亚型选择性,我们使用 κ 选择性拮抗剂 JDTic 作为探针,对 JDTic-μ/δ/κ-OR 复合物进行了一系列计算模拟,包括分子动力学和元动力学。从模拟中,我们发现 JDTic 对 μ 亚型选择性的决定性因素是 2.63 位,它通过改变 Q 残基的动力学来影响 JDTic 的效力。除了 2.63 位残基外,7.35 位是 JDTic 对 δ 亚型选择性的另一个关键方面。基于这些结果,我们提出了一个新概念,即“消息-地址-效能”假说,以解释 ORs 与阿片类药物之间的亲和力、选择性和功能之间的关系。因此,JDTic 结合的 ORs 的所有详细动力学都可能有助于深入了解其他 GPCRs 的亚型选择性和结合机制。

相似文献

1
Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.通过 JDTic 的结合和解离,计算洞察阿片受体的亚型选择性和“信息-地址-功效”机制。
Acta Pharmacol Sin. 2018 Mar;39(3):482-491. doi: 10.1038/aps.2017.132. Epub 2017 Oct 19.
2
Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.首个对μ、δ、κ和孤啡肽阿片受体具有纳摩尔亲和力的小分子阿片类全拮抗剂的发现。
ACS Chem Neurosci. 2015 Apr 15;6(4):646-57. doi: 10.1021/cn500367b. Epub 2015 Feb 18.
3
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.鉴定(3R)-7-羟基-N-((1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基)-1,2,3,4-四氢-3-异喹啉甲酰胺为一种新型强效选择性阿片κ受体拮抗剂。
J Med Chem. 2003 Jul 3;46(14):3127-37. doi: 10.1021/jm030094y.
4
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
5
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.新型氟烷基选择性 κ 阿片受体拮抗剂 JDTic 衍生物:设计、合成、药理学和分子模拟研究。
Eur J Med Chem. 2015 Jan 27;90:742-50. doi: 10.1016/j.ejmech.2014.12.016. Epub 2014 Dec 11.
6
Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes.解析人κ-阿片受体复合物的构象状态、动力学及结合机制。
J Chem Inf Model. 2014 Aug 25;54(8):2294-308. doi: 10.1021/ci5002873. Epub 2014 Jul 25.
7
Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).选择性κ阿片受体拮抗剂(3R)-7-羟基-N-((1S)-1-{[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基}-2-甲基丙基)-1,2,3,4-四氢-3-异喹啉甲酰胺(JDTic)类似物的合成及其体外阿片受体功能拮抗作用
J Med Chem. 2008 Mar 27;51(6):1849-60. doi: 10.1021/jm701344b. Epub 2008 Feb 29.
8
Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.JDTic的药理学特性:一种新型κ-阿片受体拮抗剂。
Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9. doi: 10.1016/j.ejphar.2004.08.028.
9
Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.选择性 κ 阿片受体拮抗剂诺布啡、GNTI 和 JDTic 对非阿片受体和转运体的亲和力较低。
PLoS One. 2013 Aug 14;8(8):e70701. doi: 10.1371/journal.pone.0070701. eCollection 2013.
10
Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in Rats.大鼠中JDTic样κ-阿片受体拮抗剂的作用持续时间与其脑和血浆药代动力学之间的药效学关系
ACS Chem Neurosci. 2016 Dec 21;7(12):1737-1745. doi: 10.1021/acschemneuro.6b00249. Epub 2016 Oct 4.

引用本文的文献

1
Structural basis of tolvaptan binding to the vasopressin V receptor.托伐普坦与血管加压素 V 受体结合的结构基础。
Acta Pharmacol Sin. 2024 Nov;45(11):2441-2449. doi: 10.1038/s41401-024-01325-5. Epub 2024 Jun 20.
2
Involvement of the Opioid Peptide Family in Cancer Progression.阿片肽家族在癌症进展中的作用
Biomedicines. 2023 Jul 14;11(7):1993. doi: 10.3390/biomedicines11071993.
3
Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus.含 5-降冰片烯-2-甲酰胺核的血清素能配体的合成、对接研究和药理学评价。
Molecules. 2022 Oct 1;27(19):6492. doi: 10.3390/molecules27196492.

本文引用的文献

1
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.G蛋白偶联受体的功能选择性:推动大麻素受体成为药物靶点。
Biochem Pharmacol. 2017 Mar 15;128:1-11. doi: 10.1016/j.bcp.2016.11.014. Epub 2016 Nov 24.
2
Structure-based discovery of opioid analgesics with reduced side effects.基于结构的副作用减少的阿片类镇痛药的发现。
Nature. 2016 Sep 8;537(7619):185-190. doi: 10.1038/nature19112. Epub 2016 Aug 17.
3
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
4
In vivo veritas, the next frontier for functionally selective GPCR ligands.体内真实性,功能选择性GPCR配体的下一个前沿领域。
Methods. 2016 Jan 1;92:64-71. doi: 10.1016/j.ymeth.2015.08.018. Epub 2015 Aug 28.
5
Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.对A、B和C类G蛋白偶联受体(GPCR)的配体识别和选择性的结构见解。
Eur J Pharmacol. 2015 Sep 15;763(Pt B):196-205. doi: 10.1016/j.ejphar.2015.05.013. Epub 2015 May 14.
6
Functional selectivity of GPCR signaling in animals.动物中 G 蛋白偶联受体信号的功能选择性。
Curr Opin Cell Biol. 2014 Apr;27:102-8. doi: 10.1016/j.ceb.2013.11.010. Epub 2013 Dec 22.
7
Molecular control of δ-opioid receptor signalling.δ-阿片受体信号转导的分子调控。
Nature. 2014 Feb 13;506(7487):191-6. doi: 10.1038/nature12944. Epub 2014 Jan 12.
8
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.LY2456302 是一种新型、强效、口服生物利用度的小分子 κ 选择性拮抗剂,在动物模型中具有预测情绪和成瘾障碍疗效的活性。
Neuropharmacology. 2014 Feb;77:131-44. doi: 10.1016/j.neuropharm.2013.09.021. Epub 2013 Sep 23.
9
Development of κ opioid receptor antagonists.κ 阿片受体拮抗剂的研制。
J Med Chem. 2013 Mar 28;56(6):2178-95. doi: 10.1021/jm301783x. Epub 2013 Feb 14.
10
Recent developments in the study of opioid receptors.阿片受体研究的最新进展。
Mol Pharmacol. 2013 Apr;83(4):723-8. doi: 10.1124/mol.112.083279. Epub 2012 Dec 18.